The rising interest in GLP-1 agonists for diabetes has generated a question about delivery routes : skin-applied devices versus pills . Traditionally , GLP-1 therapies were solely available in oral form, but https://montylmfo917430.blogsvila.com/41288486/glp-1-skin-applications-vs-tablets-which-right-for-you